Herbas VPB

Print
EN | LT
LT - COMPOSITIONS OF AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY
EN - COMPOSITIONS OF AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/4245
A61P 3/10
A61P 7/00
A61P 9/00
A61P 11/00
A61P 25/00
A61P 25/28
A61P 35/00
European patent
(11) Number of the document 1874306
(13) Kind of document T
(96) European patent application number 06749439.3
Date of filing the European patent application 2006-04-06
(97) Date of publication of the European application 2008-01-09
(45) Date of publication and mention of the grant of the patent 2012-07-04
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2006/012887
Date 2006-04-06
PCT application publication
(87) Number WO 2006/110483
Date 2006-10-19
Priority applications
(30) Number Date Country code
669789 P 2005-04-08 US
787395 P 2006-03-30 US
Inventors
(72)
HIRAWAT, Samit, US
MILLER, Langdon, US
Grantee
(73) PTC Therapeutics, Inc., 100 Corporate Court, Middlesex Business Center, South Plainfield, NJ 07080, US
Title
(54) COMPOSITIONS OF AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY
  COMPOSITIONS OF AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY